Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study

被引:19
|
作者
Levy, Liran [1 ]
Tigert, Alexander [1 ]
Huszti, Ella [2 ]
Saito, Tomohito [3 ]
Mitsakakis, Nicholas [2 ]
Moshkelgosha, Sajad [1 ]
Joe, Betty [1 ]
Boonstra, Kristen M. [1 ]
Tikkanen, Jussi M. [1 ]
Keshavjee, Shaf [1 ]
Juvet, Stephen C. [1 ]
Martinu, Tereza [1 ]
机构
[1] Univ Toronto, Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON, Canada
[2] Univ Toronto, Univ Hlth Network, Biostat Res Unit, Toronto, ON, Canada
[3] Kansai Med Univ, Dept Thorac Surg, Hirakata, Osaka, Japan
基金
加拿大健康研究院;
关键词
bronchoalveolar lavage; epithelial cell death; lung transplant; M30; M65; survival; BRONCHIOLITIS OBLITERANS SYNDROME; IDIOPATHIC PULMONARY-FIBROSIS; CLASSIFICATION; PATHOGENESIS; FORMULATION; TRANSITION; BIOMARKERS; NECROSIS; SERUM; FLUID;
D O I
10.1111/tri.13444
中图分类号
R61 [外科手术学];
学科分类号
摘要
Chronic lung allograft dysfunction (CLAD) remains the leading cause of late death after lung transplantation. Epithelial injury is thought to be a key event in the pathogenesis of CLAD. M30 and M65 are fragments of cytokeratin-18 released specifically during epithelial cell apoptosis and total cell death, respectively. We investigated whether M30 and M65 levels in bronchoalveolar lavage (BAL) correlate with CLAD subtypes: restrictive allograft syndrome (RAS) versus bronchiolitis obliterans syndrome (BOS). BALs were obtained from 26 patients with established CLAD (10 RAS, 16 BOS) and 19 long-term CLAD-free controls. Samples with concurrent infection or acute rejection were excluded. Protein levels were measured by ELISA. Variables were compared using Kruskal-Wallis, Mann-Whitney U test and Chi-squared tests. Association of M30 and M65 levels with post-CLAD survival was assessed using a Cox PH models. M65 levels were significantly higher in RAS compared to BOS and long-term CLAD-free controls and correlated with worse post-CLAD survival. Lung epithelial cell death is enhanced in patients with RAS. Detection of BAL M65 may be used to differentiate CLAD subtypes and as a prognostic marker in patients with established CLAD. Understanding the role of epithelial cell death in CLAD pathogenesis may help identify new therapeutic targets to improve outcome.
引用
收藏
页码:965 / 973
页数:9
相关论文
共 50 条
  • [41] The Association Between Tacrolimus Levels and Hyperkalemia in Allograft Recipients Who Underwent Heart or Lung Transplantation in New Orleans, USA Between 2013 and 2019: A Single-Center Retrospective Study
    Griffis, Olivia L.
    Thai, Steven Q.
    Allison, Cody
    Baetz, Brooke
    Mohammed, Alaa
    ANNALS OF TRANSPLANTATION, 2022, 27
  • [42] Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study
    Zhang, Wenjie
    Li, Sumei
    Zhang, Chufeng
    Mu, Zhengshuai
    Chen, Kaili
    Xu, Zhenshu
    ACTA ONCOLOGICA, 2023, 62 (08) : 853 - 860
  • [43] Predictive Value of Preoperative Peak Oxygen Uptake for Postoperative Pulmonary Complications in Lung Cancer Patients with Chronic Obstructive Pulmonary Disease: A Single-Center Retrospective Cohort Study
    Noguchi, Masaya
    Takemoto, Toshiki
    Shiraishi, Masashi
    Sugiya, Ryuji
    Mizusawa, Hiroki
    Kimura, Tamotsu
    Tamaki, Akira
    Tsutani, Yasuhiro
    Higashimoto, Yuji
    ONCOLOGY, 2025,
  • [44] Prognostic Factors in Japanese EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Real-World Single-Center Retrospective Cohort Study
    Takashima, Kenta
    Wakabayashi, Hiroki
    Murakami, Yu
    Saiki, Atsuhito
    Matsuzawa, Yasuo
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (04) : 603 - 615
  • [45] Effectiveness of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease after lobectomy due to non-small cell lung cancer - a single-center retrospective study
    Klimczak, Magdalena
    Piekielny, Damian
    Antczak, Adam
    Smigielski, Jacek
    Tworek, Damian
    ADVANCES IN RESPIRATORY MEDICINE, 2021, 89 (03) : 247 - 253
  • [46] Timing of stereotactic radiosurgery within the first-line systemic treatment in non-small cell lung cancer brain metastases: a retrospective single-center cohort study
    Bodensohn, Raphael
    Kolorz, Anna
    Reis, Jonas
    Werner, Simone
    Forbrig, Robert
    Garny, Sylvia
    Taugner, Julian
    de Colle, Chiara
    Belka, Claus
    Manapov, Farkhad
    von Baumgarten, Louisa
    Niyazi, Maximilian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (07)
  • [47] Safety and Feasibility of Video-Assisted Thoracoscopic Day Surgery and Inpatient Surgery in Patients With Non-small Cell Lung Cancer: A Single-Center Retrospective Cohort Study
    Dong, Yingxian
    Shen, Cheng
    Wang, Yan
    Zhou, Kun
    Li, Jue
    Chang, Shuai
    Ma, Hongsheng
    Che, Guowei
    FRONTIERS IN SURGERY, 2021, 8
  • [48] Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patients
    Hosoya, Kazutaka
    Ozasa, Hiroaki
    Tanji, Masahiro
    Yoshida, Hiroshi
    Ajimizu, Hitomi
    Tsuji, Takahiro
    Yoshida, Hironori
    Terada, Yukinori
    Sano, Noritaka
    Mineharu, Yohei
    Miyamoto, Susumu
    Hirai, Toyohiro
    Arakawa, Yoshiki
    BMC CANCER, 2024, 24 (01)
  • [49] Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study
    Sinn, K.
    Mosleh, B.
    Steindl, A.
    Zoechbauer-Mueller, S.
    Dieckmann, K.
    Widder, J.
    Steiner, E.
    Klepetko, W.
    Hoetzenecker, K.
    Laszlo, V
    Doeme, B.
    Klikovits, T.
    Hoda, M. A.
    ESMO OPEN, 2022, 7 (02)
  • [50] Survival benefit of thoracic radiotherapy plus EGFR-TKIs in patients with non-oligometastatic advanced non-small-cell lung cancer: a single-center retrospective study
    Zhou, Fangyuan
    Qin, You
    Liu, Xixi
    Huang, Jing
    Wu, Bian
    Zhang, Zhanjie
    Yin, Zhongyuan
    Yang, Jinsong
    Zhang, Sheng
    Jiang, Ke
    Yang, Kunyu
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15